1. Home
  2. SER vs XPL Comparison

SER vs XPL Comparison

Compare SER & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • XPL
  • Stock Information
  • Founded
  • SER 2017
  • XPL 1984
  • Country
  • SER United States
  • XPL United States
  • Employees
  • SER N/A
  • XPL N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • XPL Precious Metals
  • Sector
  • SER Health Care
  • XPL Basic Materials
  • Exchange
  • SER Nasdaq
  • XPL Nasdaq
  • Market Cap
  • SER 56.5M
  • XPL 47.9M
  • IPO Year
  • SER 2018
  • XPL N/A
  • Fundamental
  • Price
  • SER $5.40
  • XPL $0.73
  • Analyst Decision
  • SER Strong Buy
  • XPL Strong Buy
  • Analyst Count
  • SER 2
  • XPL 1
  • Target Price
  • SER $13.00
  • XPL $1.20
  • AVG Volume (30 Days)
  • SER 23.9K
  • XPL 114.3K
  • Earning Date
  • SER 08-08-2025
  • XPL 08-08-2025
  • Dividend Yield
  • SER N/A
  • XPL N/A
  • EPS Growth
  • SER N/A
  • XPL N/A
  • EPS
  • SER N/A
  • XPL N/A
  • Revenue
  • SER $51,000.00
  • XPL N/A
  • Revenue This Year
  • SER N/A
  • XPL N/A
  • Revenue Next Year
  • SER N/A
  • XPL N/A
  • P/E Ratio
  • SER N/A
  • XPL N/A
  • Revenue Growth
  • SER N/A
  • XPL N/A
  • 52 Week Low
  • SER $3.81
  • XPL $0.54
  • 52 Week High
  • SER $11.57
  • XPL $0.89
  • Technical
  • Relative Strength Index (RSI)
  • SER 45.42
  • XPL 63.28
  • Support Level
  • SER $5.11
  • XPL $0.65
  • Resistance Level
  • SER $5.67
  • XPL $0.69
  • Average True Range (ATR)
  • SER 0.38
  • XPL 0.03
  • MACD
  • SER -0.01
  • XPL 0.01
  • Stochastic Oscillator
  • SER 38.52
  • XPL 96.08

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About XPL Solitario Resources Corp.

Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.

Share on Social Networks: